No Data
No Data
Retail Investors Invested in BrightGene Bio-Medical Technology Co., Ltd. (SHSE:688166) up 7.7% Last Week, Insiders Too Were Rewarded
Brightgene Bio-Medical Technology Co., Ltd. (688166.SH) plans to distribute RMB 0.96 per 10 shares in 2023. The ex-right and ex-dividend date is July 4th.
Brightgene Bio-medical Technology Co., Ltd. (688166.SH) announced that it plans to distribute cash to all shareholders in 2023 at a rate of 10 shares per share...
BrightGene Bio-Medical Technology Co., Ltd.'s (SHSE:688166) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
BrightGene Bio-Medical Technology Co., Ltd.'s (SHSE:688166) 26% Share Price Surge Not Quite Adding Up
BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3%
Gelonghui Announcements Selected | Borui Pharmaceutical: Plans to raise no more than 500 million yuan in capital from actual controllers; Shengda Biotech: “Demonstration of full biosynthesis technology and green manufacturing for major vitamin products” p
[Hot Focus] Zhengdan Shares (300641.SZ): Serious abnormal fluctuations in stock and convertible bond trading Zhengdan Shares (300641.SZ) announced that trading prices of the company's shares and convertible bonds have fluctuated greatly recently. In order to protect investors' interests, the company will conduct suspension checks on recent abnormal fluctuations in stock and convertible bond transactions. Following the application, trading of the company's shares (stock abbreviation: Zhengdan shares, stock code: 300641) and convertible bonds (bond abbreviation: Zhengdan Convertible Bonds, bond code: 123106) will be suspended from the opening of the market on May 7, 2024, pending the company's completion of relevant inspections
No Data